We anticipate that our findings will contribute to the development of new strategies for cancer treatment that involve targeting the tumor microenvironment, and targeting PLOD2 may be a credible therapeutic strategy for breast cancer metastasis via directly inhibiting cancer migration and indirectly blocking adipocyte-derived collagen reorganization. Here, PLOD2 is linked to breast carcinoma.